마취 및 호흡 기기 시장 : 시장 규모, 점유율 및 동향 분석 보고서 - 제품 유형별, 지역별, 부문 예측(2025-2033년)

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices, Anesthesia Devices), By Region (North America, Europe, Asia Pacific, Latin America), And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,845,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,332,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,305,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

마취 및 호흡 기기 시장 요약

세계의 마취 및 호흡 기기 시장 규모는 2024년 563억 달러로 평가되었고, 2025-2033년 연평균 복합 성장률(CAGR) 5.6%로 성장할 전망이며, 2033년까지 915억 달러에 이를 것으로 예측됩니다.

이 산업은 폐쇄성 수면 무호흡증(OSA) 및 만성 폐색성 폐질환(COPD)과 같은 호흡기 질환의 발생률 증가, 급속한 도시화, 수술 건수 증가, 오염 수준, 고령화 인구, 흡연 인구 증가로 인한 것입니다.

예를 들어 호주 보건복지연구소에 따르면 2023년에는 COPD가 호흡기 질환으로 인한 질병 부담 전체의 50%, 전체 질병 부담의 3.6%를 차지했습니다. 또한 미국 폐협회에 따르면, 2022년에는 성인의 4.6%(1,170만 명)가 만성 기관지염, COPD, 또는 폐기종의 진단을 받았다고 보고하고 있습니다.

흡연 인구 증가는 폐기종, 기관지염, 암 및 기타 폐 질환과 같은 호흡기 질환의 발병률 상승으로 이어지고 있으며, 이는 호흡 기기 수요 증가를 촉진하고, 시장 성장을 뒷받침하고 있습니다. 2023년 7월에 발표된 WHO의 데이터에 의하면, 담배의 사용은 세계에서 연간 800만 명 이상의 사망 원인이 되고 있습니다. 이 중 700만 명 이상은 직접적인 담배 소비에 기인하고, 약 130만 명은 비흡연자에 있어서 수동 흡연에 의한 것입니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 마취 및 호흡 기기 시장의 변수, 동향 및 범위

• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회
• 마취 및 호흡 기기 시장 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 마취 및 호흡 기기 시장 : 제품 유형별 추정 및 동향 분석

• 시장 점유율 : 제품 유형별(2024년, 2033년)
• 부문 대시보드
• 제품 유형별 시장 전망
  • 마취 기기
  • 호흡 기기

제5장 마취 및 호흡 기기 시장 : 제품별 지역별 추정 및 동향 분석

• 시장 점유율 분석 : 지역별(2024년, 2033년)
• 지역별 시장 대시보드
• 세계 지역 시장 현황
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제6장 경쟁 구도

• 주요 시장 진출 기업에 의한 최근의 동향 및 영향 분석
• 기업 및 경쟁 분류
• 주요 기업의 시장 점유율 및 위치 분석(2024년)
• 기업 프로파일
  • Medtronic
  • Teleflex Incorporated
  • Koninklijke Philips NV
  • Dragerwerk AG &Co. KGaA
  • Getinge AB.
  • Smiths Group plc
  • Fisher &Paykel Healthcare Limited.
  • Masimo
  • B. Braun Melsungen AG
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Inogen, Inc.
  • Caire Medical(a subsidiary of NGK Spark Plug)
  • DeVilbiss Healthcare(a subsidiary of Drive Medical).
  • React Health(Respiratory Product Line from Invacare Corporation)
  • O2 Concepts
  • Nidek Medical Products, Inc.
  • Omron Corporation
  • GE Healthcare
  • Allied Healthcare
  • Vectura Group Plc.
  • PARI Respiratory Equipment, Inc.
  • Aerogen
  • Beurer
  • Briggs Healthcare

AJY

영문 목차

영문목차

Anesthesia And Respiratory Devices Market Summary

The global anesthesia and respiratory devices market size was estimated at USD 56.3 billion in 2024 and is expected to reach USD 91.5 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The industry is driven by an increased incidence of respiratory disorders such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), fast urbanization, an increase in surgical operations, pollution levels, a geriatric population, and a smoking population.

For instance, according to the Australian Institute of Health and Welfare, in 2023, COPD accounted for 50% of the total burden of disease due to respiratory conditions and 3.6% of the total disease burden. Furthermore, according to the American Lung Association, in 2022, 4.6% of adults, or 11.7 million people, reported a diagnosis of chronic bronchitis, COPD, or emphysema.

The rising population of smokers is also leading to the increasing incidence of respiratory diseases, such as emphysema, bronchitis, cancer, and other lung diseases, which is leading to the growing demand for respiratory devices, hence boosting the market growth. According to WHO data published in July 2023, tobacco use is responsible for over 8 million deaths annually worldwide. Of these, more than 7 million are attributed to direct tobacco consumption, while approximately 1.3 million are due to second-hand smoke exposure among non-smokers.

Global Anesthesia And Respiratory Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anesthesia and respiratory devices market report based on product and region:

• Product Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Respiratory Devices
  • Respiratory Equipment
  • Humidifiers
  • Heat Humidifiers
  • Heated Wire Breathing Circuits
  • Heat Exchangers
  • Pass Over Humidifiers
  • Nebulizers
  • Pneumatic Nebulizers
  • Mesh Nebulizers
  • Ultrasonic Nebulizers
  • Oxygen Concentrator
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Positive Airway Pressure Devices
  • Bilevel & automatic positive airway pressure devices
  • Continuous positive airway pressure devices
  • Reusable Resuscitators
  • Ventilators
  • Adult Ventilators
  • Neonatal Ventilators
  • Respiratory Inhalers
  • Dry Powdered Inhalers
  • Metered Dose Inhaler
  • Respiratory Disposables
  • Disposable Oxygen Masks
  • Resuscitators
  • Tracheostomy Tubes
  • Oxygen Cannula
  • Respiratory Measurement Devices
  • Pulse Oximetry systems
  • Capnographs
  • Spirometers
  • Peak Flowmeters
• Anesthesia Devices
  • Anesthesia Machines
  • Anesthesia Workstation
  • Anesthesia delivery machines
  • Portable
  • Standalone
  • Anesthesia Ventilators
  • Anesthesia Monitors
  • Anesthesia Disposables
  • Anesthesia Masks
  • Anesthesia Accessories
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product outlook
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market driver analysis
    • 3.1.1.1. Rise In Chronic Respiratory Diseases And Geriatric Population
    • 3.1.1.2. Technological Advancements
    • 3.1.1.3. Supportive Initiatives by Government and Private Organizations
  • 3.1.2. Market Restraint analysis
    • 3.1.2.1. Product Recalls & Failure
    • 3.1.2.2. Complexity of Modern Anesthesia and Respiratory Machines
  • 3.1.3. Market Opportunities
• 3.2. Anesthesia and Respiratory Devices Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape

Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Type Market Share, 2024 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Brain Computer Interface Market by Product Type Outlook
  • 4.3.1. Anesthesia Devices
    • 4.3.1.1. Anesthesia Devices market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1.1. Anesthesia Machines
        • 4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.1.2. Anesthesia Workstation
          • 4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.1.3. Anesthesia Delivery Machines
          • 4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.3.2. Portable Anesthesia Delivery Machine
            • 4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.3.3. Standalone Anesthesia Delivery Machine
            • 4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.1.4. Anesthesia Ventilators
          • 4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.1.5. Anesthesia Monitors
          • 4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1.2. Anesthesia Disposables
        • 4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.2.2. Anesthesia Masks
          • 4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.2.3. Anesthesia Accessories
          • 4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Respiratory Devices
    • 4.3.2.1. Respiratory devices market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.1.1. Respiratory Equipment
        • 4.3.2.1.1.1. Respiratory Equipment's market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.2. Humidifiers
          • 4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.2.2. Heat Humidifiers
            • 4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.2.3. Heated wire breathing circuits
            • 4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.2.4. Heat Exchangers
            • 4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.2.5. Pass Over Humidifiers
            • 4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.3. Nebulizers
          • 4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.3.2. Pneumatic nebulizers
            • 4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.3.3. Mesh nebulizers
            • 4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.3.4. Ultrasonic nebulizers
            • 4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.4. Oxygen Concentrators
          • 4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.4.2. Fixed Oxygen Concentrators
            • 4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.4.3. Portable Oxygen Concentrators
            • 4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.5. Positive airway pressure devices
          • 4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.5.2. Bi-level positive airway pressure devices
            • 4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.5.3. Continuous positive airway pressure devices
            • 4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.6. Reusable resuscitators
          • 4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.7. Ventilators
          • 4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.7.2. Adult Ventilators
            • 4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.7.3. Neonatal Ventilators
            • 4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.8. Respiratory inhalers
          • 4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.8.2. Dry Powdered Inhalers
            • 4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.8.3. Metered Dose Inhalers
            • 4.3.2.1.1.8.3.1. Metered Dose Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.9. Respiratory disposable
          • 4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.9.2. Disposable Oxygen Mask
            • 4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.9.3. Resuscitators
            • 4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.9.4. Tracheostomy Tubes
            • 4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.9.5. Oxygen Cannula
            • 4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1.10. Respiratory measurement devices
          • 4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.10.2. Pulse oximetry systems
            • 4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.10.3. Capnographs
            • 4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.10.4. Spirometers
            • 4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.10.5. Peak flowmeters
            • 4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product

• 5.1. Regional Market Share Analysis, 2024 & 2033
• 5.2. Regional Market Dashboard
• 5.3. Global Regional Market Snapshot
• 5.4. North America
  • 5.4.1. U.S.
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework/ reimbursement structure
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Canada
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Mexico
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Europe
  • 5.5.1. UK
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.2. Germany
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.3. France
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework/ reimbursement structure
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.4. Italy
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework/ reimbursement structure
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.5. Spain
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework/ reimbursement structure
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.6. Norway
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework/ reimbursement structure
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.7. Sweden
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Regulatory framework/ reimbursement structure
    • 5.5.7.3. Competitive scenario
    • 5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.8. Denmark
    • 5.5.8.1. Key country dynamics
    • 5.5.8.2. Regulatory framework/ reimbursement structure
    • 5.5.8.3. Competitive scenario
    • 5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Japan
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework/ reimbursement structure
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.2. China
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.3. India
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework/ reimbursement structure
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.4. Australia
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework/ reimbursement structure
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.5. South Korea
    • 5.6.5.1. Key country dynamics
    • 5.6.5.2. Regulatory framework/ reimbursement structure
    • 5.6.5.3. Competitive scenario
    • 5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.6. Thailand
    • 5.6.6.1. Key country dynamics
    • 5.6.6.2. Regulatory framework/ reimbursement structure
    • 5.6.6.3. Competitive scenario
    • 5.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Latin America
  • 5.7.1. Brazil
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework/ reimbursement structure
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.2. Argentina
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 5.8. MEA
  • 5.8.1. South Africa
    • 5.8.1.1. Key country dynamics
    • 5.8.1.2. Regulatory framework/ reimbursement structure
    • 5.8.1.3. Competitive scenario
    • 5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8.2. Saudi Arabia
    • 5.8.2.1. Key country dynamics
    • 5.8.2.2. Regulatory framework/ reimbursement structure
    • 5.8.2.3. Competitive scenario
    • 5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8.3. UAE
    • 5.8.3.1. Key country dynamics
    • 5.8.3.2. Regulatory framework/ reimbursement structure
    • 5.8.3.3. Competitive scenario
    • 5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8.4. Kuwait
    • 5.8.4.1. Key country dynamics
    • 5.8.4.2. Regulatory framework/ reimbursement structure
    • 5.8.4.3. Competitive scenario
    • 5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Key company market share/position analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Medtronic
    • 6.4.1.1. Company Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Teleflex Incorporated
    • 6.4.2.1. Company Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Koninklijke Philips N.V.
    • 6.4.3.1. Company Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Dragerwerk AG & Co. KGaA
    • 6.4.4.1. Company Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Getinge AB.
    • 6.4.5.1. Company Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Smiths Group plc
    • 6.4.6.1. Company Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. Fisher & Paykel Healthcare Limited.
    • 6.4.7.1. Company Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Masimo
    • 6.4.8.1. Company Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. B. Braun Melsungen AG
    • 6.4.9.1. Company Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. ResMed
    • 6.4.10.1. Company Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 6.4.11.1. Company Overview
    • 6.4.11.2. Financial Performance
    • 6.4.11.3. Product Benchmarking
    • 6.4.11.4. Strategic initiatives
  • 6.4.12. Inogen, Inc.
    • 6.4.12.1. Company Overview
    • 6.4.12.2. Financial Performance
    • 6.4.12.3. Product Benchmarking
    • 6.4.12.4. Strategic initiatives
  • 6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
    • 6.4.13.1. Company Overview
    • 6.4.13.2. Financial Performance
    • 6.4.13.3. Product Benchmarking
    • 6.4.13.4. Strategic initiatives
  • 6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical).
    • 6.4.14.1. Company Overview
    • 6.4.14.2. Financial Performance
    • 6.4.14.3. Product Benchmarking
    • 6.4.14.4. Strategic initiatives
  • 6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
    • 6.4.15.1. Company Overview
    • 6.4.15.2. Financial Performance
    • 6.4.15.3. Product Benchmarking
    • 6.4.15.4. Strategic initiatives
  • 6.4.16. O2 Concepts
    • 6.4.16.1. Company Overview
    • 6.4.16.2. Financial Performance
    • 6.4.16.3. Product Benchmarking
    • 6.4.16.4. Strategic initiatives
  • 6.4.17. Nidek Medical Products, Inc.
    • 6.4.17.1. Company Overview
    • 6.4.17.2. Financial Performance
    • 6.4.17.3. Product Benchmarking
    • 6.4.17.4. Strategic initiatives
  • 6.4.18. Omron Corporation
    • 6.4.18.1. Company Overview
    • 6.4.18.2. Financial Performance
    • 6.4.18.3. Product Benchmarking
    • 6.4.18.4. Strategic initiatives
  • 6.4.19. GE Healthcare
    • 6.4.19.1. Company Overview
    • 6.4.19.2. Financial Performance
    • 6.4.19.3. Product Benchmarking
    • 6.4.19.4. Strategic initiatives
  • 6.4.20. Allied Healthcare
    • 6.4.20.1. Company Overview
    • 6.4.20.2. Financial Performance
    • 6.4.20.3. Product Benchmarking
    • 6.4.20.4. Strategic initiatives
  • 6.4.21. Vectura Group Plc.
    • 6.4.21.1. Company Overview
    • 6.4.21.2. Financial Performance
    • 6.4.21.3. Product Benchmarking
    • 6.4.21.4. Strategic initiatives
  • 6.4.22. PARI Respiratory Equipment, Inc.
    • 6.4.22.1. Company Overview
    • 6.4.22.2. Financial Performance
    • 6.4.22.3. Product Benchmarking
    • 6.4.22.4. Strategic initiatives
  • 6.4.23. Aerogen
    • 6.4.23.1. Company Overview
    • 6.4.23.2. Financial Performance
    • 6.4.23.3. Product Benchmarking
    • 6.4.23.4. Strategic initiatives
  • 6.4.24. Beurer
    • 6.4.24.1. Company Overview
    • 6.4.24.2. Financial Performance
    • 6.4.24.3. Product Benchmarking
    • 6.4.24.4. Strategic initiatives
  • 6.4.25. Briggs Healthcare
    • 6.4.25.1. Company Overview
    • 6.4.25.2. Financial Performance
    • 6.4.25.3. Product Benchmarking
    • 6.4.25.4. Strategic initiatives

관련자료